Enlivex Therapeutics Ltd.
ENLV | NASDAQ
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.29
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 6:29 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.11B | 2.21B | 1.24B | -12.7M | -13.1M | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Depreciation & Amortization | 278K | 302.5K | 332K | 292K | 372K | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 496K | 411K | 349K |
Stock-Based Compensation | 1.2M | 1.49M | 1.78M | 1.79M | 1.88M | 1.98M | 2.07M | 1.55M | 1.58M | 1.7M | 1.95M | 2.31M | 2.37M | 2.56M | 2.71M | 3.65M | 3.56M | 3.51M | 2.91M | 1.36M | 1.19M | 728K |
Other Working Capital | 8.49M | 4.96M | 958.53K | -423.92K | -1.48M | -736.99K | -1.56M | -523K | 1.26M | -1.28M | -697K | -1.48M | -1.21M | -2.26M | -364K | -953K | -2.99M | -1.44M | -1.8M | -1.7M | -801K | -805K |
Other Non-Cash Items | -4.13B | -2.23B | -1.25B | -1.42M | -547.79K | -484.79K | 621.21K | 3.6M | 2.87M | 2.91M | 3.1M | 852K | -2.05M | -2.05M | -2.07M | -2.06M | 88K | -83K | -216K | -385K | 208K | 186K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 102K | 336K | 1.73M | 1.73M | 1.63M | 4.31M | 4.89M | 1.51M | 1.51M | -2.61M | -4.96M | -1.58M | -1.58M | -388K |
Change in Working Capital | 8.55M | 5.03M | 865.81K | 169.6K | -1.13M | -733.21K | -1.23M | -870K | 212K | -1.77M | -1.82M | -1.65M | -68K | -2.03M | 804K | -928K | -2.86M | -417K | -1.36M | -1.01M | -793K | -771K |
Operating Cash Flow | -15.8M | -11.54M | -10.69M | -11.87M | -12.52M | -13.12M | -13.01M | -13.95M | -16.77M | -22M | -23.27M | -23.06M | -24.22M | -26.47M | -23.95M | -25.73M | -23.33M | -18.47M | -17.54M | -16.71M | -14.86M | -14.13M |
Capital Expenditures | -41.94K | -44.44K | -71.94K | -97.55K | -83K | -92K | -103K | -73.94K | -93.94K | -115.94K | -234.94K | -2.81M | -3.97M | -7.33M | -8.12M | -6.57M | -5.5M | -2.4M | -1.63M | -1.07M | -1.33M | -1.15M |
Cash Acquisitions | 514.13K | 514.13K | 514.13K | 303.51K | 303.51K | 303.51K | 527.51K | 272.92K | 271.65K | 352.33K | 128.33K | 68.75K | 24.78K | 1.39M | 1.39M | 1.4M | 1.45M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -9.02M | -16.36M | -25.9M | -25.52M | -30.59M | -33.39M | -32.33M | -27.03M | -10.6M | -3.5M | -26.2M | -30.23M | 1.03M | -30.86M | -1.6M | -15.69M | -55.56M | -36.59M | -104.42M | -94.3M | -93.65M | -87.71M |
Sales Maturities Of Investments | 23.19M | 31.36M | 43.78M | 36.15M | 37.04M | 38.2M | 39.18M | 34.82M | 22.73M | 13.7M | 295.07K | -11.45K | 9.99M | 8.29M | 70.84M | 80.91M | 89.99M | 119.84M | 67.63M | 57.87M | 38.78M | 10.34M |
Other Investing Acitivies | -8.47M | -3.99M | 591.59K | 570.4K | 2.33M | 2.12M | 1.79M | 1.81M | 40.63K | 7.04K | -24.15K | -24.44K | 15.07K | -21.16K | 10.02K | 10.32K | -34.92K | n/a | n/a | -3.96K | -7.96K | -17.96K |
Investing Cash Flow | -14.5M | -9.19M | -1.77M | 11.42M | 9M | 7.13M | 9.06M | 9.8M | 12.35M | 10.44M | -26.01M | -32.98M | 7.12M | -28.5M | 62.52M | 60.05M | 30.34M | 80.86M | -38.41M | -37.5M | -56.2M | -78.53M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 23.06M | 11.52M | -24.23K | -22.23K | 1.87K | 42.51K | 42.51K | 40.51K | 40.51K | n/a | n/a | 42.85 | 2.34K | 4.6K | 4.6K | 4.56K | -293.95K | -398.72K | 7.34M | 15.86M | 16.16M | 16.36M |
Financial Cash Flow | 33.87M | 22.33M | 10.99M | 1.81M | 1.71M | 6.13M | 6.45M | 5.19M | 4.94M | 559.15K | 353.15K | 353.41K | 408.98K | 416.98K | 148.98K | 147K | 164K | 116K | 60.98M | 71.51M | 71.45M | 71.54M |
Net Cash Flow | -2.37M | -2.5M | -1.38M | 1.34M | -1.82M | 139K | 2.51M | 812K | 288K | -11.22M | -49.15M | -55.68M | -16.69M | -54.55M | 38.72M | 34.72M | 6.97M | 62.69M | 4.62M | 16.93M | 691K | -20.27M |
Free Cash Flow | -16.17M | -11.91M | -11.09M | -12.3M | -12.61M | -13.21M | -13.11M | -14.02M | -16.87M | -22.11M | -23.51M | -25.87M | -28.19M | -33.8M | -32.08M | -32.3M | -28.84M | -20.88M | -19.17M | -17.78M | -16.19M | -15.28M |
Adj. Free Cash Flow | -17.37M | -13.4M | -12.87M | -14.08M | -14.49M | -15.19M | -15.18M | -15.57M | -18.44M | -23.82M | -25.46M | -28.18M | -30.56M | -36.36M | -34.79M | -35.95M | -32.4M | -24.39M | -22.08M | -19.15M | -17.38M | -16.01M |
Maintenance CapEx | -41.94K | -44.44K | -71.94K | -97.55K | -83K | -92K | -103K | -73.94K | -93.94K | -115.94K | -234.94K | -2.81M | -3.97M | -7.33M | -8.12M | -6.57M | -5.5M | -2.4M | -1.63M | -1.07M | -1.33M | -1.15M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -15.85M | -11.58M | -10.76M | -11.97M | -12.61M | -13.21M | -13.11M | -14.02M | -16.87M | -22.11M | -23.51M | -25.87M | -28.19M | -33.8M | -32.08M | -32.3M | -28.84M | -20.88M | -19.17M | -17.78M | -16.19M | -15.28M |
Add to Watchlist
Select watchlists to add or remove ENLV